Delivery Order 36C24819D0005-36C24823N0028
Award Date 10/1/22
Potential Completion Date 9/30/23
Potential Value $8.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tampa, FL 33612, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) located in Tampa, Florida. The contract, valued at $15,602,467.00, is focused on early therapeutic development with an emphasis on Phase II clinical trials. The contract is not set aside for any specific business type. Moffitt Cancer Center, a nonprofit, NCI-designated...
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a National Cancer Institute-designated comprehensive cancer center in Tampa, Florida, was awarded a delivery order valued at $525,665.30 by the National Heart, Lung, and Blood Institute under the Production Assistance for Cellular Therapies–Cell Processing Facilities (PACT-CPF) master IDIQ vehicle. This contract, issued on October 31, 2018, with completion targeted for June 1, 2020, calls for cell manufacturing and process...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $102,053.00 firm fixed-price purchase order to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc., a nonprofit hospital and National Cancer Institute-designated comprehensive cancer center, for the procurement of DNA samples to support a multi-ancestry genome-wide association study of lymphoid malignancies. The contract does not utilize any small business set-asides and...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. The $1,317,908.89 delivery order contract is for the "National Myelodysplastic Syndromes (MDS) Natural History Study - Central Laboratory and Biorepository." The contract has a completion date of June 29, 2018 and did not use any small business set-asides....
- This contract was awarded by the National Institutes of Health (NIH) National Heart Lung and Blood Institute to the H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. for production assistance for cellular therapies (PACT) - cell processing facilities. The contract has a potential value of $488,251.00 and does not utilize a small business set-aside. It is a delivery order under the larger PACT-CPF master indefinite delivery/indefinite quantity (IDIQ) contract, which provides...
- H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. was awarded a delivery order against the National Myelodysplastic Syndromes (MDS) Natural History Study indefinite-delivery/indefinite-quantity contract by the Department of Health and Human Services' National Institutes of Health National Heart, Lung, and Blood Institute. The $928,450.64 delivery order is for central laboratory and biorepository services in support of the MDS Natural History Study, which aims to improve...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center), a nonprofit hospital and comprehensive cancer center. The $14,833.00 contract is for genotyping services and does not have a set-aside designation. Moffitt Cancer Center has received various federal contracts and grants to support cancer research, including...
- The National Heart Lung and Blood Institute awarded a delivery order valued at $761,385.23 to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. on June 3, 2019, with completion targeted for March 31, 2022. This contract falls under the Production Assistance for Cellular Therapies–Cell Processing Facilities (PACT-CPF) master IDIQ vehicle and supports cell manufacturing and process development services for a Factor VIII TCR-engineered Treg cell product (PCT0025-01). The award...
- <p>The National Cancer Institute awarded a purchase order to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. valued at $147,750 on July 13, 2026, for corrective editing of splicing factor mutant myelodysplastic syndromes and chronic myelomonocytic leukemia. Performance will be completed by July 12, 2027, at the place of performance in Bethesda, Maryland. The contract is priced on a firm fixed-price basis with no small business set-aside applied.</p>
- Foundation Medicine, Inc. was awarded a $0.00 firm fixed price delivery order against an unspecified multiple award contract vehicle to provide hematologic malignancies testing services for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The one-year contract, which contains no set-aside designation, requires the contractor to complete the hematologic malignancies testing by September 30, 2022 for the VA network headquartered in Riviera...